Levine Cancer Institute - Main

1021 Morehead Medical Drive
Charlotte, North Carolina 28204

We've found

1 trials

at this facility

LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple M

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Charlotte, NC

Use our guide to learn which trials are right for you!